The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases

Thrombosis Research

Volumn 82, Issue 3, 1996, Pages 245-255

  Grau, Armin J ^a   Buggle, Florian ^b   Becher, Heiko ^b   Werle, Egon ^b   Hacke, Werner ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NONE

Author keywords

C reactive protein; Coronary heart disease; Fibrinogen; Leukocytes; Stroke; Vascular risk factors

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RISK FACTOR; STROKE; VASCULAR DISEASE;

EID: 0029980157     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00071-0     Document Type: Article

References (38)

1. STUART, J., GEORGE, A.J., DAVIES, A.J., AUKLAND, A., HURLOW, R.A. Haematological stress syndrome in atherosclerosis. J Clin Pathol 34, 464-467, 1981.
2. MUNRO, J.M. and COTRAN, R.S. The pathogenesis of atherosclerosis: Atherogenesis and inflammation. Lab Invest 58, 249-261, 1988.
3. KOSTIS, J.B., TURKEVICH D., SHARP J. Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary arteriography. Am J Cardiol 53, 997-999, 1984.
4. BOLIBAR, I., KIENAST, J., THOMPSON J., MATTHIAS R., NIESSNER H., FECHTRUP C. Relation of fibrinogen to presence and severity of coronary artery disease is independent of other coexisting heart disease. Am Heart J 725, 1601-1605, 1993.
5. MORI, T., SASAKI, J., KAWAGUCHI, K., HANDA, K., TAKADA, Y., MATSUNAGA A., KONO, S., ARAKAWA, K. Serum glycoproteins and severity of coronary atherosclerosis. Am Heart J 729, 234-238, 1995.
6. WILHELMSEN, L., SVÄRDSUDD, K., KORSAN-BENGTSEN, K., LARSSON, B., WELIN, L., TIBBLIN, G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 311, 501-505, 1984.
7. ERNST, E., RESCH, K.L. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature. Ann Intern Med 118, 956-963, 1993.
8. FRIEDMAN, G.D., KLATSKY, A.L., SIEGELAUB, A.B. The leukocyte count as a predictor of myocardial infarction. N Engl J Med 290, 1275-1278, 1974.
9. ZALOKAR, J.B., RICHARD, J.L., CLAUDE, J.R. Leukocyte count, smoking, and myocardial infarction. N Engl J Med 304, 465-468, 1981.
10. PRENTICE, R.L., SZATROWSKI, T.P., KATO, H., MASON, M.W.: Leukocyte counts and cerebrovascular disease. J Chron Dis 35, 703-714, 1982.
11. KANNEL, W.B., ANDERSON, K., WILSON, P.W.F. White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA 267, 1253-1256, 1992.
12. GILLUM, R.F., INGRAM, D.D., MAKUC, D.M. White blood cell count and stroke incidence and death. The HNANES I epidemiologic follow-up study. Am J Epidemiol 139, 894-902, 1994.
13. GROTTA, J.C., YATSU, P.M., PETTIGREW, L.C., RHOADES, H., BRATINA, P., VITAL, D., ALAM, R., EARLS, R., PICONE, C. Prediction of carotid stenosis progression by lipid and hematologic measurements. Neurology 39, 1325-1331, 1989.
14. HEINRICH, J., SCHULTE, H., SCHONFELD, R., KÖHLER, E., ASSMANN, G. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost 73, 374-379, 1995.
15. McMILLAN, D.E. Increased levels of acute-phase serum proteins in diabetes. Metabolism 38, 1042-1046, 1989.
16. CORRE, F., LELLOUCH, SCHWARTZ, D., Smoking and leucocyte counts. Lancet ii, 632-634, 1971.
17. HANSEN, L.K., GRIMM, R.H., NEATON, J.D. The relationship of white blood cell count to other cardiovascular risk factors. Int J Epidemiol 4, 881-888, 1990.
18. FACCHINI, F., HOLLENBECK, C.B., CHEN, Y.N., CHEN, Y.D.I., REAVEN, G.M. Demonstration of a relationship between white blood cell count, insulin resistance, and several risk factors for coronary heart disease in women. J Intern Med 232, 267-272, 1992.
19. ERNST, E., HAMMERSCHMIDT, D.E., BAGGE, U., MATRAI, A., DORMANDY, J.A. Leukocytes and the risk of ischemic diseases. JAMA 257, 2318-2323, 1987.
20. KLING, D., HOLZSCHUH, T., BETZ, E. Recruitment and dynamics of leukocytes in the formation of arterial intimal thickening - A comparative study with normo- and hypercholesterolemic rabbits. Atherosclerosis 101, 79-96, 1993.
21. CERMAK, J., KEY, N.S., BACH, R.R., BALLA, J., JACOB H.S., VERCELLOTTI, G.M. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82, 513-520, 1993.
22. GALVE-DE ROCHEMONTEIX, B., WIKTOROWICZ, K., KUSHNER, I., DAYER, I.M. C-reactive protein increases production of IL-1a, IL-1b, and TNF-a, and expression of mRNA by human alveolar macrophages. J Leukoc Biol 53, 439-445, 1993.
23. SCHLEEF, R.R., BEVILACQUA, M.P., SAWDEY, M., GIMBRONE, M.A., LOSKUTOFF, D.J. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem 263, 5797-5803, 1988.
24. HALLENBECK, J.M., DUTKA, A.J., VOGEL, S.N., HELDMAN, E., DORON, D.A., FEUERSTEIN, G. Lipopolysaccharide-induced production of tumor necrosis factor activity in rats with and without risk factors for stroke. Brain research 541, 115-120, 1991.
25. HALLENBECK, J.M., DUTKA, A.J., KOCHANEK, P.M., SIREN, A., PEZESHKPOUR, G.H., FEUERSTEIN, G. Stroke risk factors prepare rat brainstem tissues for modified local Shwartzman reaction. Stroke 19, 863-869, 1988.
26. GRAU, A.J., BUGGLE, F., HEINDL, S., STEICHEN-WIEHN, C., BANERJEE, T., MAIWALD, M., ROHLFS, M., SUHR, H., FIEHN, W., BECHER, H., HACKE, W. Recent infection as a risk factor for cerebrovascular ischemia. Stroke 26, 373-379, 1995.
27. MEADE, T.W., CHAKRABARTI, R., HAINES, A.P., HORTH, W.R.S., STIRLING, Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. BMJ i, 153-156, 1979.
28. GLUECK, C.J., GLUECK, H.I., STROOP, D., SPEIRS, J., HAMER, T., TRACY, T. Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipemic men. J Lab Clin Med 722, 412-420, 1993.
29. ASSMANN G. and SCHULTE, H. The importance of triglycerides: results from the Prospective Cardiovascular Munster (PROCAM) Study. Eur J Epidemiol 8 Suppl. 1, 99-103, 1992.
30. GANDA, O.P. and ARKIN, C.F. Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes. Diab Care 75, 1245-1250, 1992.
31. PRENTICE, R.L., SZATROWSKI, T.P., FUJIKURA, T., KATO, H., MASON, M.W., HAMILTON, H.H. Leukocyte counts and coronary heart disease in a japanese cohort. Am J Epidem 116, 496-509, 1982.
32. GRIMM, R.H., NEATON, J.D., LUDWIG, W. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA 254, 1932-1937, 1985.
33. LEE, A.J., LOWE, G.D.O., WOODWARD, M., TUNSTALL-PEDOE, H. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: The Scottish Heart Health Study. Br Heart J 69, 338-342, 1993.
34. KANNEL, W.B. Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham Study. Am Heart J 114, 413-419, 1987.
35. SCHMID-SCHÖNBEIN, G.W., SEIFFGE, G., DeLANO, F.A., SHEN, K., ZWEIFACH, B.W. Leukocyte counts and activation in spontaneously hypertensive and normotensive rats. Hypertension 17, 323-330, 1991.
36. FRIEDMAN, G.D., TEKAWA, I., GRIMM, R.H., MANOLIO, T., SHANNON, S.G., SIDNEY, S. The leucocyte count: Correlates and relationship to coronary risk factors: The CARDIA study 19, 889-893, 1990.
37. ANACHENKO, V.G., VAKOLYUK, R.M., KUZNETSOV, S.V., MALASHENKOVA, I.K., STREITSOVA, T.V., STRIZHOVA, N.V. The NBT test in hypertensive patients. Sovietskaia meditsina 10, 3-5, 1986.
38. GRAU, A.J., SEITZ, R., IMMEL, A., STEICHEN-WIEHN, C., HACKE, W. Increased levels of leukocyte elastase in ischemic stroke and in subjects with vascular risk factors. Cerebrovasc Dis 5, 50-54, 1995.